NEW YORK, Aug 11 ― Antibody levels are a good predictor for how effective Moderna Inc's Covid-19 vaccine is, according to a new study released on Tuesday, a finding which could help speed up future clinical trials for vaccines against the disease.
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high levels of antibodies. These recipients also reported a lower rate of breakthrough infections after being vaccinated.
Of-course but allergic persons can't be jabbed with Moderna.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: